FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3119476051> ?p ?o ?g. }

• W3119476051 endingPage "S107" @default.
• W3119476051 startingPage "S107" @default.
• W3119476051 abstract "Abstract Background Fever and neutropenia (FN) is common in cancer patients after chemotherapy, and there are national guideline recommendations for FN prevention and treatment. We conducted a survey of practices across multiple US cancer centers to determine the extent to which these guidelines have been adapted. Methods US cancer centers performing 20 allogeneic hematopoietic stem cell transplantations annually were identified from the National Marrow Donor Program’s “Be the Match” directory. Antimicrobial stewardship physicians and pharmacists at each institution were identified using institutional websites, residency or fellowship program directories, and personal contacts. A survey assessing institutional practices and individual attitudes on FN management in high-risk patients was distributed via email. Duplicate responses at the hospital level were removed. Complete surveys regarding individual attitudes were assessed using a 5-point Likert scale ranging from “Strongly Agree” to “Strongly Disagree.” Results Thirty-four (23%) responses from 148 individuals were received, representing 31 of 86 hospitals (36%). 29 (94%) hospitals reported having guidelines for the management of FN. Of these, cefepime was the most commonly recommended agent for empiric treatment (26, 90%) and 16 (55%) provide guidance based on presumed site of infection. Eighteen (62%) hospitals recommend de-escalation of Gram negative therapy in certain situations, most often after being afebrile 48 – 72 hours or after neutrophil recovery (7 each, 39%). Twenty-seven (93%) hospitals recommended antibiotic prophylaxis, most often with levofloxacin (21, 78%). Of 34 respondents, attitudes were split regarding the statement “The benefit of antibiotic prophylaxis outweighs the harms in high-risk patients” (10 strongly agree or agree, 10 strongly disagree or disagree; 29% each); most agreed with the statement “I would use antibiotic prophylaxis in high-risk patients” (25, 78%). Conclusion Most cancer centers across the US have guidelines for the management of FN. While most recommend antibacterial prophylaxis, there were differences in individual perceptions regarding the risk / benefit. Significant variation exists in the approach to antibiotic de-escalation. Disclosures All Authors: No reported disclosures" @default.
• W3119476051 created "2021-01-18" @default.
• W3119476051 creator A5000249065 @default.
• W3119476051 creator A5038835015 @default.
• W3119476051 creator A5071722034 @default.
• W3119476051 creator A5091592847 @default.
• W3119476051 creator A5091663701 @default.
• W3119476051 date "2020-10-01" @default.
• W3119476051 modified "2023-10-03" @default.
• W3119476051 title "208. Variation in Clinical Practice and Attitudes in the Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States" @default.
• W3119476051 doi "https://doi.org/10.1093/ofid/ofaa439.252" @default.
• W3119476051 hasPublicationYear "2020" @default.
• W3119476051 type Work @default.
• W3119476051 sameAs 3119476051 @default.
• W3119476051 citedByCount "0" @default.
• W3119476051 crossrefType "journal-article" @default.
• W3119476051 hasAuthorship W3119476051A5000249065 @default.
• W3119476051 hasAuthorship W3119476051A5038835015 @default.
• W3119476051 hasAuthorship W3119476051A5071722034 @default.
• W3119476051 hasAuthorship W3119476051A5091592847 @default.
• W3119476051 hasAuthorship W3119476051A5091663701 @default.
• W3119476051 hasBestOaLocation W31194760511 @default.
• W3119476051 hasConcept C126322002 @default.
• W3119476051 hasConcept C2776040555 @default.
• W3119476051 hasConcept C2776694085 @default.
• W3119476051 hasConcept C2777063308 @default.
• W3119476051 hasConcept C2778850193 @default.
• W3119476051 hasConcept C501593827 @default.
• W3119476051 hasConcept C512399662 @default.
• W3119476051 hasConcept C71924100 @default.
• W3119476051 hasConcept C86803240 @default.
• W3119476051 hasConcept C89423630 @default.
• W3119476051 hasConcept C94665300 @default.
• W3119476051 hasConceptScore W3119476051C126322002 @default.
• W3119476051 hasConceptScore W3119476051C2776040555 @default.
• W3119476051 hasConceptScore W3119476051C2776694085 @default.
• W3119476051 hasConceptScore W3119476051C2777063308 @default.
• W3119476051 hasConceptScore W3119476051C2778850193 @default.
• W3119476051 hasConceptScore W3119476051C501593827 @default.
• W3119476051 hasConceptScore W3119476051C512399662 @default.
• W3119476051 hasConceptScore W3119476051C71924100 @default.
• W3119476051 hasConceptScore W3119476051C86803240 @default.
• W3119476051 hasConceptScore W3119476051C89423630 @default.
• W3119476051 hasConceptScore W3119476051C94665300 @default.
• W3119476051 hasIssue "Supplement_1" @default.
• W3119476051 hasLocation W31194760511 @default.
• W3119476051 hasLocation W31194760512 @default.
• W3119476051 hasLocation W31194760513 @default.
• W3119476051 hasOpenAccess W3119476051 @default.
• W3119476051 hasPrimaryLocation W31194760511 @default.
• W3119476051 hasRelatedWork W2032467468 @default.
• W3119476051 hasRelatedWork W2110910968 @default.
• W3119476051 hasRelatedWork W2769063687 @default.
• W3119476051 hasRelatedWork W2792025196 @default.
• W3119476051 hasRelatedWork W2896912046 @default.
• W3119476051 hasRelatedWork W3017554704 @default.
• W3119476051 hasRelatedWork W3119408265 @default.
• W3119476051 hasRelatedWork W4220775537 @default.
• W3119476051 hasRelatedWork W4311833239 @default.
• W3119476051 hasRelatedWork W1892468111 @default.
• W3119476051 hasVolume "7" @default.
• W3119476051 isParatext "false" @default.
• W3119476051 isRetracted "false" @default.
• W3119476051 magId "3119476051" @default.
• W3119476051 workType "article" @default.